parkinson's and glp 1 GLP-1 Disease: Research, Benefits and Risks Glucagon-like peptide-1 medicines in neurological

Name: parkinson's and glp 1 GLP-1 Disease: Research, Benefits and Risks Glucagon-like peptide-1 medicines in neurological
Brand: buntepalette-gmbh.de
SKU: 26886420476
Price: 26.54 USD
Availability: InStock
Rating: 4.2097 (10 reviews)

SKU: 26886420476

4.2

USD26.54 USD52.54

Pay in 4 interest-free payments of $6.63 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Live Spec

Glucagon like peptide 1 medicines in neurological and psychiatric disorders: Cell Reports Medicine GLP 1 Receptor Agonists for Parkinson's Disease: Promise or Mirage? The glucagon like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action ScienceDirect Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease Molecular Psychiatry

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

Recently, increasing evidence indicates that functional autophagy is required for synaptic functions, including neurotransmission and synaptic plasticity (75)